ArticleFEBS open bio2023

Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.

Hirofumi Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.